文献速递细胞病理与分子病理神经与头颈病理

用于口腔潜在恶性病变筛查与评估的即时口腔细胞学工具

Point-of-care oral cytology tool for the screening and assessment of potentially malignant oral lesions.
PubMed 文献 · Cancer Cytopathol · 2020-02-07

基于999例口腔潜在恶性病变(PMOL)和口腔鳞状细胞癌(OSCC)患者的多中心临床验证研究,开发了结合机器学习与细胞学芯片的即时检测工具。自动细胞学检测与机器学习模型识别4种细胞表型的准确率达99.3%,临床算法区分良性 vs 轻度异型增生和良性 vs 恶性的曲线下面积分别为0.81和0.95。该工具可辅助病理医生和临床医生快速评估PMOL,有望用于初筛和纵向监测。

要点

  • 机器学习辅助细胞学芯片可自动识别和量化4种细胞表型,准确率99.3%。
  • 临床算法区分良性 vs 轻度异型增生AUC为0.81,良性 vs 恶性AUC为0.95。
  • 该工具为PMOL的快速评估和纵向监测提供了实用方案。

核心结论

  • 新型细胞病理学工具(含机器学习算法、临床算法和检测报告)为PMOL的快速评估提供了实用解决方案,有望促进初级、二级和三级诊疗中的筛查与纵向监测。

研究设计与样本

  • 多中心临床验证研究,纳入999例PMOL和OSCC受试者,采用细胞学芯片方法采集数据。
  • 训练机器学习模型识别和量化4种细胞表型,并训练lasso逻辑回归模型基于人口学、病变特征和细胞表型区分PMOL与癌。
  • 开发细胞病理学软件辅助病理医生审阅刷检细胞学结果,包括高内涵细胞分析、数据可视化工具和结果报告。

主要发现

  • 自动细胞学检测联合机器学习方法确定细胞表型的准确率达99.3%。
  • 3种细胞表型(类型1「成熟鳞状」、类型2「小圆」、类型3「白细胞」)在不同诊断类别间的分布存在显著差异。
  • 临床算法区分良性 vs 轻度异型增生的AUC为0.81,区分良性 vs 恶性的AUC为0.95。

关键数值与推荐

  • 细胞表型自动识别准确率99.3%。
  • 良性 vs 轻度异型增生AUC为0.81;良性 vs 恶性AUC为0.95。

临床怎么用

  • 该工具可辅助病理医生和临床医生对PMOL进行快速评估,并可能用于初级、二级和三级诊疗中的筛查与纵向监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effective detection and monitoring of potentially malignant oral lesions (PMOL) are critical to identifying early-stage cancer and improving outcomes. In the current study, the authors described cytopathology tools, including machine learning algorithms, clinical algorithms, and test reports developed to assist pathologists and clinicians with PMOL evaluation. METHODS: Data were acquired from a multisite clinical validation study of 999 subjects with PMOLs and oral squamous cell carcinoma (OSCC) using a cytology-on-a-chip approach. A machine learning model was trained to recognize and quantify the distributions of 4 cell phenotypes. A least absolute shrinkage and selection operator (lasso) logistic regression model was trained to distinguish PMOLs and cancer across a spectrum of histopathologic diagnoses ranging from benign, to increasing grades of oral epithelial dysplasia (OED), to OSCC using demographics, lesion characteristics, and cell phenotypes. Cytopathology software was developed to assist pathologists in reviewing brush cytology test results, including high-content cell analyses, data visualization tools, and results reporting. RESULTS: Cell phenotypes were determined accurately through an automated cytological assay and machine learning approach (99.3% accuracy). Significant differences in cell phenotype distributions across diagnostic categories were found in 3 phenotypes (type 1 ["mature squamous"], type 2 ["small round"], and type 3 ["leukocytes"]). The clinical algorithms resulted in acceptable performance characteristics (area under the curve of 0.81 for benign vs mild dysplasia and 0.95 for benign vs malignancy). CONCLUSIONS: These new cytopathology tools represent a practical solution for rapid PMOL assessment, with the potential to facilitate screening and longitudinal monitoring in primary, secondary, and tertiary clinical care settings.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. McRae MP, Modak SS, Simmons GW, et al. Point-of-care oral cytology tool for the screening and assessment of potentially malignant oral lesions. Cancer Cytopathol. 2020. PMID: 32032477. doi:10.1002/cncy.22236

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。